No CVD Issues Apparent Years After Aromatase Inhibitor Therapy

The findings in breast cancer survivors are 'reassuring,' given the benefit of aromatase inhibitors, the authors say. The study was published as a preprint and has not yet been peer reviewed.
First Look

source https://www.medscape.com/viewarticle/975262?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?